Nodular lymphocyte predominant hodgkin lymphoma with clusters of lp cells, acute inflammation, and fibrosis: A syncytial variant

American Journal of Surgical Pathology

Volumn 33, Issue 11, 2009, Pages 1725-1731

  Drakos, Elias ^a   Rassidakis, George Z ^a,b   Leventaki, Vassiliki ^a,c   Cotta, Claudiu V ^a,d   Vega, Francisco ^a   Medeiros, L Jeffrey ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hodgkin lymphoma; Lymphocyte predominant; Nodular sclerosis; Syncytial variant

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL INFILTRATION; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; NEUTROPHIL CHEMOTAXIS; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FIBROSIS; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHADENITIS; LYMPHOCYTES; LYMPHOMA, FOLLICULAR; MALE; NEUTROPHILS; RADIOTHERAPY, ADJUVANT; SCLEROSIS; TUMOR MARKERS, BIOLOGICAL; VINBLASTINE;

EID: 70350441394     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181b27765     Document Type: Article

References (20)

1. Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 2000;96: 1889-1899.
2. Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/ histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/ histiocyte-rich B-cell lymphoma. Blood. 2003;102:3753-3758.
3. Brune V, Tiacci E, Pfeil I, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205:2251-2268.
4. De Wolf-Peeters C, Delabie J, Campo E, et al. T cell/histiocyte-rich large B-cell lymphoma. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:338-1239
5. Drakos E, Leventaki V, Schlette EJ, et al. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Am J Surg Pathol. 2007;31:447-453.
6. Fan Z, Natkunam Y, Bair E, et al. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27:1346-1356.
7. Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood. 1999;94:3108-3113.
8. Greiner TC, Gascoyne RD, Anderson ME, et al. Nodular lymphocyte- predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood. 1996;88:657-666.
9. Hansmann ML, Stein H, Fellbaum C, et al. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol. 1989;20:1169-1175.
10. Mathas S, Hinz M, Anagnostopoulos I, et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J. 2002;21:4104-4113.
11. Nogova L, Reineke T, Brillant C, et al. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol. 2008;26:434-439.
12. Pellegrino B, Terrier-Lacombe MJ, Oberlin O, et al. Lymphocyte- predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection-a Study of the French Society of Pediatric Oncology. J Clin Oncol. 2003;21:2948-2952.
13. Rassidakis GZ, Medeiros LJ, Viviani S, et al. CD20 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin's Disease: Associations With Presenting Features and Clinical Outcome. J Clin Oncol. 2002; 20:1278-1287. (Pubitemid 34177434)
14. Renne C, Martin-Subero JI, Eickernjager M, et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol. 2006;169:655-664.
15. Stein H. Hodgkin lymphoma. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:322-334.
16. Strickler JG, Michie SA, Warnke RA, et al. The ''syncytial variant'' of nodular sclerosing Hodgkin's disease. Am J Surg Pathol. 1986; 10:470-477.
17. Sundeen JT, Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent ''large cell lymphoma''. Histological progression or composite malignancy?. Am J Surg Pathol. 1988;12:599-606.
18. Tedoldi S, Mottok A, Ying J, et al. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. J Pathol. 2007; 213:429-440.
19. Torlakovic E, Tierens A, Dang HD, et al. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol. 2001;159:1807-1814.
20. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17: 2257-2317